How can we help?
Broad portfolio of affordable high quality inhaled products are under development.
Our portfolio includes Long Acting Beta Agonists(LABA) and Inhaled Cortico Steroids(ICS) in different strengths and combinations to enable step-up or step-down asthma treatment regimes.
For more extreme conditions, our development includes Inhaled Long-Acting Muscarinic Antagonists(LAMAs) for COPD.
Respirent is exploring new and innovative ways to improve the delivery and effectiveness our medicines to benefit our customers.